Is my smelly yellow vaginal discharge due to STD?

Hi,

Welcome to icliniq.com.

I got your concern about vaginal discharge.

Based on the description, yellow, bad‑smelling discharge with intermittent itch for months, the most likely cause is bacterial vaginosis, with trichomoniasis as an important alternative to rule out, and both are straightforward to test and treat in the clinic. A same‑week pelvic exam with bedside vaginitis tests and sexually transmitted infections nucleic acid testing is recommended to confirm the diagnosis and guide therapy safely.

The probable causes in your case look like:

• Bacterial vaginosis (BV): Typically causes a thin, gray‑to‑yellow discharge with a strong “fishy” odor, often more noticeable after sex, and may cause mild itching or irritation. BV reflects a shift in vaginal flora rather than a classic sexually transmitted infection (STI), but it is associated with sexual activity and increases susceptibility to other STIs.

• Trichomoniasis: Often presents with yellow‑green discharge that can be frothy, with malodor and vulvar itching or irritation, and requires specific testing because it is sexually transmitted and common in young adults. Nucleic acid amplification tests (NAATs) are preferred for diagnosis due to superior sensitivity over microscopy.

• Vulvovaginal candidiasis: This causes intense vulvar itch with thick “cottage‑cheese” discharge and usually lacks a strong odor; pH typically remains normal, distinguishing it from BV or trichomonas. It is diagnosed clinically with microscopy or by response to standard azole therapy in uncomplicated cases.

• Cervicitis due to chlamydia or gonorrhea: This may cause mucopurulent discharge from the cervix and can be asymptomatic; NAAT screening is recommended in sexually active young adults with persistent discharge. Cervicitis can coexist with vaginitis and should be considered when discharge persists or is mucopurulent on a speculum exam.

Looking at all of these, I will suggest you get following investigations done:

• Pelvic exam with bedside vaginitis testing:

  • Vaginal pH.

  • Whiff (amine) test.

  • Saline or potassium hydroxide wet mount to look for clue cells (BV), motile trichomonads, or yeast forms, applying Amsel criteria for BV where available.

  • If microscopy is unavailable or inconclusive, consider validated NAAT or other approved tests for BV per local availability.

• Nucleic acid amplification test (NAAT) swabs or urine: Test for trichomonas, chlamydia, and gonorrhea using vaginal or cervical swabs or first‑catch urine per lab protocol, given the chronic discharge and STI concern. Follow guideline‑based panels in the 2021 STI treatment guidelines for comprehensive evaluation and management.

• Consider broader STI screening as indicated by risk (example: human immunodeficiency virus and syphilis), given that BV and trichomoniasis are associated with increased STI acquisition risk, and coinfections can occur.

The differential diagnosis in your case includes:

1. Bacterial vaginosis.

2. Trichomoniasis.

3. Vaginal Candidiasis.

4. Cervicitis due to chlamydia or gonorrhea.

In your case, it looks like you are suffering from Bacterial vaginosis.

I would suggest the following treatment plan:

• If BV is confirmed, Metronidazole 500 mg orally twice daily for seven days, or Metronidazole 0.75% gel 5 g intravaginally once daily for five days, are recommended regimens. Treating male partners is not recommended for BV, and recurrence is common, so follow‑up if symptoms recur is appropriate.

• If trichomoniasis is confirmed, Metronidazole 500 mg orally twice daily for seven days is first‑line for women, and sexual partners require presumptive treatment to prevent reinfection, with retesting at three months because repeat infection is common. NAAT is preferred for diagnosis and also for retesting after treatment when indicated by local practice and timing considerations.

• If vulvovaginal candidiasis is confirmed and uncomplicated, either a single oral Fluconazole 150 mg dose or a three to seven-day topical azole regimen is an effective option; avoid oral azoles in pregnancy and use topical azoles for seven days if pregnant. Partner treatment is not indicated for uncomplicated candidiasis.

As preventive measures, you can:

1. Avoid douching and scented or antiseptic intimate products, as these disrupt vaginal flora and increase the risk of BV and recurrent symptoms. Use condoms and keep sex toys clean to reduce STI risk and BV recurrence linked to sexual activity.

2. Seek testing and treatment before resuming unprotected sex if trichomoniasis or other STIs are suspected, because partner management is crucial to prevent reinfection. BV itself is not typically an STI, but symptom control and risk‑reduction practices are still important.

• Urgent evaluation is advised if lower abdominal or pelvic pain, fever, dyspareunia, or abnormal bleeding develop, as these can indicate pelvic inflammatory disease requiring prompt treatment to prevent complications. Pelvic inflammatory disease guidance emphasizes timely care to reduce risks such as infertility and chronic pelvic pain.

• Arrange a clinic visit this week for exam, bedside tests, and NAATs, with treatment initiated or adjusted based on confirmed results. If trichomoniasis, chlamydia, or gonorrhea are diagnosed, retesting at three months helps detect repeat infection per guidance.

• If symptoms persist after guideline‑directed therapy or if tests are negative but discharge continues, reassessment for mixed infections, cervicitis, or noninfectious causes is appropriate per STI guideline principles. Recurrence after BV is common; return for evaluation if malodor or discharge recurs to consider alternative regimens or suppressive strategies as per guidance.

I hope this answers your query.

Thank you.